“a decreasing trend”

Besides, IHC images showed the abundance of CD8 + T cells had a decreasing trend in HB tumor (p = 0.0516) in each sample (Fig. 7 f, g).

The XPc treatment, at 1 mg/kg IP, failed to affect GFAP IF in all three areas, although a decreasing trend was noted in PoDG ( p = 0.052 vs.

Thus, the changes in weight were shown to exhibit a decreasing trend at 24 weeks in the CETP T allele group ( p = 0.052; GG group weight change − 2.56%, GT group weight change − 8.24%; Fig. 2 B).

[ 70 ] reported a decreasing trend close to significance ( p = 0.052), while Iaffaldano et al.

A decreasing trend in carbohydrate intake was observed with increasing AGE intake, approaching statistical significance ( p = 0.052).

After 24 h incubation, a decreasing trend was observed, in which 12.3% of the cells were positive ( P = .052).

Furthermore, there was an increasing trend in the proportion of propionate ( P = 0.076) and a decreasing trend in the proportion of butyrate ( P = 0.052).

Although we found no differences in the ADFI and F/G between HS and PF groups, birds in the HS group displayed a decreasing trend ( P = 0.052) in the ADG in comparison with birds in the PF group, which suggested that the impairment of growth performance caused by HS was partly independent of the decreased feed intake.

There were significant decreases in the scores of incomplete evacuation feeling (Q6) and headaches (Q9), and there was a decreasing trend in the score of bloating (Q4, p < 0.052) for those administered the enzyme mixture compared with those administered the placebo.

Hom mice showed a decreasing trend with no statistically significant difference ( p = 0.052) compared with the wt in the open arm entry frequency (Supplementary Fig. 2 ).

The amount of the BAs per mg faeces did not change significantly after the probiotic intervention, being the 12-oxilithocholic acid the only BA metabolite with a decreasing trend at Day 28 ( P = 0.052 vs. baseline).

Cephalosporins also showed a decreasing trend (IRR = 0.87, p = 0.0520), similar to findings from Silva-Costa et al., where pediatric invasive pneumococcal disease cases initially declined before rebounding post-pandemic [ 39 ].

Although EDV showed a decreasing trend, the change was not statistically significant ( P = 0.052).

Foxo1 expression also showed a decreasing trend (p = 0.052).

The richness of Gram-positive bacteria showed a marked increasing trend ( P = 0.052), while Gram-negative bacteria had a decreasing trend ( P = 0.052) by MCR treatments.

showed [ 64 ] that after 3 months of treatment with megestrol (a synthetic progestin that has been shown to increase appetite in patients [ 65 ]), the weight and BMI of dialysis patients increased significantly compared to the previous period and the changes were statistically significant ( p < 0.05); a decreasing trend towards total cholesterol concentration in the first 2 months of treatment ( p = 0.052) was also seen.

Although a decreasing trend in adherence was observed across groups, the between-group difference was not statistically significant (χ 2 = 5.93, df = 2, p = 0.052).

− 0.03 ± 0.13 placebo), and a decreasing trend ( p = 0.0522) on Day 14 (− 0.35 ± 0.12 for VE vs. − 0.06 ± 0.09 placebo) (Fig. 5 b).

The daily number of high impacts decreased in the QCT subgroup (−101; SD, 553; P = 0.047), whereas in the full data set, only a decreasing trend was observed (−27; SD, 679; P = 0.053).

The PostOB hunger score (TFEQ3) showed a decreasing trend in comparison to PreOB ( P = 0.053), close to the level of NW (PostOB vs NW, P = 0.980) ( Table 1 ).

Interestingly, Aβo-induced pHrodo index in microglia was reduced by GW9662 at the third and sixth hours, and a decreasing trend was explained in the first hour ( P = 0.053).

Upon comparing different treatments, a decreasing trend ( p = 0.053) in bacterial titers was found for broths to which 5000 vs. 1000 μg/L cortisol was added.

In the conversion group, there may be a decreasing trend in Aβ levels compared to baseline after a 2-year follow-up ( P = 0.053), while there was no significant change in tau and P-tau (all P > 0.05).

Post-hoc analysis reported LAR levels to be significantly lower at week 4 ( p = 0.049) and week 8 ( p = 0.004) compared with baseline in the LCHF group; however, in the HCLF group only week 4 showed a decreasing trend ( p = 0.053) compared to baseline.

Moreover, the CD4SP had a decreasing trend in PNE group ( P = 0.053, Fig. 3B,D ).